Pill burden decreases and antiretroviral regimens simplify for many of the participants who start lenacapavir.

The first gene-editing therapies for HIV/Aids are entering trials but the virus is proving once again that it is a master at ...

In July 2024, we published a story with the headline: "One of the 7 people cured of HIV tells his story. Can his cure work for others." This summer, at the International AIDS Society conference, came ...

FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) today announced the presentation of late-breaking data and multiple oral presentations from its innovative HIV treatment ...

Gilead's Phase 3 ARTISTRY-1 trial shows its single-tablet HIV regimen of bictegravir and lenacapavir matches the efficacy and safety of current therapy.

FAYETTEVILE, N.C. (WTVD) -- Fayetteville native John Rowell calls the FDA's approval of the first injectable treatment for HIV pre-exposure prevention, PrEP, "monumental." The FDA said the injectable ...

"Cure" was the fresh buzzword among researchers at the XIX International AIDS Conference. It was the focus of a two-day pre-conference workshop and a new initiative by the International AIDS Society ...

Timothy Ray Brown, the first person cured of HIV, died September 29 at his home in Palm Springs, surrounded by his partner and friends, after battling a recurrence of leukemia. He was 54. Since he ...

An HIV-infected H9 T cell, as seen by a scanning electromicrograph. In a landmark first for the continent hardest hit by HIV, a new clinical trial in South Africa has delivered a rare but ...

– Investigational Long-Acting, Twice-Yearly Treatment Regimen of Lenacapavir and Broadly Neutralizing Antibodies (bNAbs) Meets Primary Endpoint in Phase 2 Study and Gains Breakthrough Therapy ...